{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:57:21Z","timestamp":1793739441061,"version":"4.6.1"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019413","name":"Yunnan Provincial Department of Education Science Research Fund Project","doi-asserted-by":"publisher","award":["2025Y0380"],"award-info":[{"award-number":["2025Y0380"]}],"id":[{"id":"10.13039\/501100019413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["2023BS20"],"award-info":[{"award-number":["2023BS20"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["2024BS08"],"award-info":[{"award-number":["2024BS08"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["2024XKTDYS03"],"award-info":[{"award-number":["2024XKTDYS03"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20240813141112017"],"award-info":[{"award-number":["JCYJ20240813141112017"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515220157"],"award-info":[{"award-number":["2024A1515220157"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300871"],"award-info":[{"award-number":["82300871"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360603"],"award-info":[{"award-number":["82360603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560157"],"award-info":[{"award-number":["82560157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118333","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:15:39Z","timestamp":1786029339000},"page":"118333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Targeting the extracellular vesicle-immune axis in prostate cancer: mechanisms of immune evasion and emerging therapeutic strategies"],"prefix":"10.1016","volume":"253","author":[{"given":"Chen","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senmao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enxiu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118333_b0005","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3390\/curroncol30020178","article-title":"Underlying features of prostate cancer\u2014statistics, risk factors, and emerging methods for its diagnosis","volume":"30","author":"Berenguer","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bcp.2026.118333_b0010","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.trecan.2020.04.010","article-title":"Advanced prostate cancer: treatment advances and future directions","volume":"6","author":"Swami","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bcp.2026.118333_b0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/1061186X.2024.2418344","article-title":"Interactions and communications in the prostate tumour microenvironment: evolving towards effective cancer therapy","volume":"33","author":"Dai","year":"2025","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bcp.2026.118333_b0020","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s10555-024-10210-w","article-title":"The biological function of extracellular vesicles in prostate cancer and their clinical application as diagnostic and prognostic biomarkers","volume":"43","author":"Limonta","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bcp.2026.118333_b0025","article-title":"Extracellular vesicles as mediators of intercellular communication","author":"Hasan","year":"2025","journal-title":"Impl. Drug Discov. Targ. Therap."},{"key":"10.1016\/j.bcp.2026.118333_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/genes8100240","article-title":"Extracellular vesicle\u2010associated RNA as a carrier of epigenetic information","volume":"8","author":"Di Liegro","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bcp.2026.118333_b0035","article-title":"The role of tumor\u2010derived extracellular vesicles in drug resistance in urologic cancers","volume":"7","author":"Xiong","year":"2024","journal-title":"Adv. Ther."},{"key":"10.1016\/j.bcp.2026.118333_b0040","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/humupd\/dmi052","article-title":"Prostasomes\u2014their effects on human male reproduction and fertility","volume":"12","author":"Burden","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.bcp.2026.118333_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1039260","article-title":"The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy","volume":"13","author":"Lu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118333_b0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/imm.13793","article-title":"Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy","volume":"173","author":"Wang","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2026.118333_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.862416","article-title":"Myeloid-derived suppressor cells as key players and promising therapy targets in prostate cancer","volume":"12","author":"Siemi\u0144ska","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2026.118333_b0060","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3390\/ijms21072286","article-title":"Extracellular vesicles and tumor-immune escape: biological functions and clinical perspectives","volume":"21","author":"Raimondo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118333_b0065","article-title":"Immunologically effective biomaterials enhance immunotherapy of prostate cancer","author":"Liu","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bcp.2026.118333_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11236892","article-title":"Extracellular vesicles and their roles in the tumor immune microenvironment","volume":"11","author":"Reale","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bcp.2026.118333_b0075","article-title":"Extracellular vesicle\/macrophage axis: potential targets for inflammatory disease intervention","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118333_b0080","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2017.1400370","article-title":"Biological roles and potential applications of immune cell-derived extracellular vesicles","volume":"6","author":"Wen","year":"2017","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.bcp.2026.118333_b0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12943-020-01199-1","article-title":"Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology","volume":"19","author":"Hu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.118333_b0090","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1039\/C8LC01123K","article-title":"Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application","volume":"19","author":"Zhao","year":"2019","journal-title":"Lab Chip"},{"key":"10.1016\/j.bcp.2026.118333_b0095","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/diagnostics11030466","article-title":"Detection and investigation of extracellular vesicles in serum and urine supernatant of prostate cancer patients","volume":"11","author":"Salvi","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.bcp.2026.118333_b0100","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.3390\/cancers15102838","article-title":"Surface-engineered extracellular vesicles in cancer immunotherapy","volume":"15","author":"Johnson","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2026.118333_b0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12951-025-03326-w","article-title":"Small extracellular vesicles: crucial mediators for prostate cancer","volume":"23","author":"Tang","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.bcp.2026.118333_b0110","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12967-024-05267-8","article-title":"The multifaceted role of extracellular vesicles (EVs) in colorectal cancer: metastasis, immune suppression, therapy resistance, and autophagy crosstalk","volume":"22","author":"Rahmati","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118333_b0115","doi-asserted-by":"crossref","first-page":"694","DOI":"10.37349\/etat.2022.00108","article-title":"The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors","volume":"3","author":"Palano","year":"2022","journal-title":"Explor. Target Anti-Tumor Ther."},{"key":"10.1016\/j.bcp.2026.118333_b0120","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1159\/000541881","article-title":"The immune microenvironment in prostate cancer: a comprehensive review","volume":"103","author":"Novysedlak","year":"2025","journal-title":"Oncology"},{"key":"10.1016\/j.bcp.2026.118333_b0125","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.3390\/cancers12123563","article-title":"Emerging role of extracellular vesicles in immune regulation and cancer progression","volume":"12","author":"Mittal","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2026.118333_b0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fimmu.2014.00127","article-title":"Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues","volume":"5","author":"Van Overmeire","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118333_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109822","article-title":"M2 macrophage-derived exosomes induce angiogenesis and increase skin flap survival through HIF1AN\/HIF-1\u03b1\/VEGFA control","volume":"751","author":"Luo","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2026.118333_b0140","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s12276-025-01465-6","article-title":"Extracellular vesicles derived from lung M2 macrophages enhance group 2 innate lymphoid cells function in allergic airway inflammation","volume":"57","author":"Lv","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bcp.2026.118333_b0145","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8580043","article-title":"The roles of tumor\u2010associated macrophages in prostate cancer","volume":"2022","author":"Han","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.bcp.2026.118333_b0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12964-023-01103-6","article-title":"A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication","volume":"21","author":"Liu","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2026.118333_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1021270","article-title":"Exosomal RNF157 mRNA from prostate cancer cells contributes to M2 macrophage polarization through destabilizing HDAC1","volume":"12","author":"Guan","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2026.118333_b0160","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7616696","article-title":"Exosomal CXCL14 contributes to M2 macrophage polarization through NF-\u03baB signaling in prostate cancer","volume":"2022","author":"Tian","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bcp.2026.118333_b0165","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.7150\/jca.81933","article-title":"Endoplasmic reticulum stress promotes prostate cancer cells to release exosome and up-regulate PD-L1 expression via PI3K\/Akt signaling pathway in macrophages","volume":"14","author":"Xu","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.bcp.2026.118333_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/genes11121495","article-title":"Extracellular vesicles-mediated transfer of miRNA Let-7b from PC3 cells to macrophages","volume":"11","author":"Costanzi","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bcp.2026.118333_b0175","doi-asserted-by":"crossref","first-page":"24560","DOI":"10.1074\/jbc.M114.571620","article-title":"Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis","volume":"289","author":"Soki","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118333_b0180","doi-asserted-by":"crossref","first-page":"9729","DOI":"10.1002\/jcp.29784","article-title":"Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer","volume":"235","author":"Guan","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2026.118333_b0185","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2025.01.006","article-title":"Identification, structure, and agonist design of an androgen membrane receptor","volume":"188","author":"Yang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118333_b0190","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1007\/s11010-025-05222-1","article-title":"Upregulation of YY1 in M2 macrophages promotes secretion of exosomes containing hsa-circ-0000326 via super-enhancers to facilitate prostate cancer progression","volume":"480","author":"Guan","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bcp.2026.118333_b0195","article-title":"Taurine Inhibits Ferroptosis Mediated by the Crosstalk between Tumor Cells and Tumor-Associated Macrophages in Prostate cancer","volume":"11","author":"Xiao","year":"2024","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Ger)"},{"key":"10.1016\/j.bcp.2026.118333_b0200","doi-asserted-by":"crossref","first-page":"26138","DOI":"10.1038\/s41598-025-11799-w","article-title":"Prostate cancer cell-derived exosomes inhibit macrophage phagocytosis through EIF3B-mediated exosomal sorting of miR-100-5p","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118333_b0205","doi-asserted-by":"crossref","first-page":"13258","DOI":"10.3390\/ijms232113258","article-title":"Crosstalk between tumor-associated macrophages and MicroRNAs: a key role in tumor microenvironment","volume":"23","author":"Zhou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118333_b0210","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1007\/s11010-023-04854-5","article-title":"Exosome miRNA-203 promotes M1 macrophage polarization and inhibits prostate cancer tumor progression","volume":"479","author":"Zhang","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bcp.2026.118333_b0215","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s40364-024-00685-8","article-title":"Exosomal PSM-E inhibits macrophage M2 polarization to suppress prostate cancer metastasis through the RACK1 signaling axis","volume":"12","author":"Qin","year":"2024","journal-title":"Biomark Res"},{"key":"10.1016\/j.bcp.2026.118333_b0220","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4161\/cbt.27627","article-title":"Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells","volume":"15","author":"Kim","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bcp.2026.118333_b0225","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2021.11.017","article-title":"Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a\/Nfatc1\/Angptl2 axis for bone metastasis","volume":"526","author":"Wang","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2026.118333_b0230","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev-pathmechdis-012418-013058","article-title":"Monocytes in the tumor microenvironment","volume":"16","author":"Ugel","year":"2021","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"key":"10.1016\/j.bcp.2026.118333_b0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.matbio.2023.11.003","article-title":"Targeting the \u03b1V\u03b23\/NgR2 pathway in neuroendocrine prostate cancer","volume":"124","author":"Testa","year":"2023","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bcp.2026.118333_b0240","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1763594","article-title":"The \u03b1v\u03b26 integrin in cancer cell-derived small extracellular vesicles enhances angiogenesis","volume":"9","author":"Krishn","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.bcp.2026.118333_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071487","article-title":"Extracellular vesicle-associated tissue factor activity in prostate cancer patients with disseminated intravascular coagulation","volume":"13","author":"Hell","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2026.118333_b0250","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3389\/fimmu.2019.01906","article-title":"CD8+ T lymphocyte and NK cell network: circuitry in the cytotoxic domain of immunity","volume":"10","author":"Uzhachenko","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118333_b0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s13577-025-01257-0","article-title":"Blocking secretion of exosomes by GW4869 dampens CD8(+) T cell exhaustion and prostate cancer progression","volume":"38","author":"Liu","year":"2025","journal-title":"Hum. Cell"},{"key":"10.1016\/j.bcp.2026.118333_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113424","article-title":"Prostate cancer cell-derived exosomal IL-8 fosters immune evasion by disturbing glucolipid metabolism of CD8(+) Tcell","volume":"42","author":"Xu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.118333_b0265","doi-asserted-by":"crossref","first-page":"16405","DOI":"10.1002\/cam4.6275","article-title":"Prostate cancer cells synergistically defend against CD8(+) T cells by secreting exosomal PD-L1","volume":"12","author":"Li","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.bcp.2026.118333_b0270","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bcmd.2005.07.001","article-title":"Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis","volume":"35","author":"Abusamra","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcp.2026.118333_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.750542","article-title":"Regulatory T cells: regulation of identity and function","volume":"12","author":"Grover","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118333_b0280","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1158\/0008-5472.CAN-06-3456","article-title":"Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2","volume":"67","author":"Clayton","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118333_b0285","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s10020-024-00947-z","article-title":"Prostate cancer cell-derived exosomes ZNF667-AS1 reduces TGFBR1 mRNA stability to inhibit Treg expansion and DTX resistance by binding to U2AF1","volume":"30","author":"Shi","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.bcp.2026.118333_b0290","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.3390\/ijms21113930","article-title":"Functional role of dendritic cell subsets in cancer progression and clinical implications","volume":"21","author":"Del Prete","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118333_b0295","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bcp.2026.118333_b0300","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2017.1368823","article-title":"Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes","volume":"6","author":"Salimu","year":"2017","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.bcp.2026.118333_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1605494","article-title":"Extracellular vesicles from prostate tumors reshape the pre-metastatic bone environment in an mTOR\/RAB1A-dependent manner","volume":"16","author":"Lv","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118333_b0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108925","article-title":"Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion","volume":"9","author":"Lundholm","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118333_b0315","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1878-0261.13422","article-title":"NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomy","volume":"17","author":"Lu","year":"2023","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2026.118333_b0320","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s44318-024-00040-5","article-title":"Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB\/IRF3 activation promotes antitumor immunity in prostate cancer","volume":"43","author":"Alaimo","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2026.118333_b0325","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bcp.2026.118333_b0330","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/s41467-026-70861-x","article-title":"Spatial heterogeneity of MDSCs mediated by ANXA1-FPRs signaling drives immune suppression in OSCC progression","volume":"17","author":"Li","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118333_b0335","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5584406","article-title":"Exosomes derived from RM-1 cells promote the recruitment of MDSCs into tumor microenvironment by upregulating CXCR4 via TLR2\/NF-\u03baB pathway","volume":"2021","author":"Li","year":"2021","journal-title":"J. Oncol."},{"key":"10.1016\/j.bcp.2026.118333_b0340","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.immuni.2025.03.005","article-title":"Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven immunosuppression through the cGAS-STING pathway","volume":"58","author":"Lai","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2026.118333_b0345","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12967-022-03494-5","article-title":"Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9\/circMID1\/miR-506-3p\/MID1","volume":"20","author":"Gao","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118333_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155471","article-title":"Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients","volume":"141","author":"Mac\u00edas","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2026.118333_b0355","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri3622","article-title":"Regulation of immune responses by extracellular vesicles","volume":"14","author":"Robbins","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2026.118333_b0360","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118333_b0365","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118333_b0370","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrrheum.2014.19","article-title":"Emerging role of extracellular vesicles in inflammatory diseases","volume":"10","author":"Buzas","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2026.118333_b0375","first-page":"984","article-title":"Macrophage microvesicles induce macrophage differentiation and miR-223 transfer","volume":"121","author":"Ismail","year":"2013","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.bcp.2026.118333_b0380","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science (80-)"},{"key":"10.1016\/j.bcp.2026.118333_b0385","doi-asserted-by":"crossref","DOI":"10.1002\/cre2.70099","article-title":"Extracellular vesicles derived from lipopolysaccharide-challenged gingival fibroblast reveal distinct miRNA expression patterns associated with reduced cancer survival","volume":"11","author":"Diehl","year":"2025","journal-title":"Clin. Exp. Dent. Res."},{"key":"10.1016\/j.bcp.2026.118333_b0390","doi-asserted-by":"crossref","DOI":"10.21037\/aob-21-3","article-title":"A narrative review of immune checkpoint mechanisms and current immune checkpoint therapy","volume":"7","author":"Peng","year":"2022","journal-title":"Ann. Blood"},{"key":"10.1016\/j.bcp.2026.118333_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2022.100073","article-title":"Novel plasma exosome biomarkers for prostate cancer progression in co-morbid metabolic disease","volume":"6","author":"Jafari","year":"2022","journal-title":"Adv. Cancer Biol. - Metastasis"},{"key":"10.1016\/j.bcp.2026.118333_b0400","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1038\/s41388-020-1270-z","article-title":"p300\/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer","volume":"39","author":"Liu","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.118333_b0405","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091276","article-title":"Extracellular vesicles from human advanced-stage prostate cancer cells modify the inflammatory response of microenvironment-residing cells","volume":"11","author":"Mezzasoma","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2026.118333_b0410","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169470","article-title":"Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles","volume":"134","author":"Ruzanov","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118333_b0415","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.radonc.2010.03.024","article-title":"Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer","volume":"95","author":"Hurwitz","year":"2010","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"10.1016\/j.bcp.2026.118333_b0420","doi-asserted-by":"crossref","first-page":"442","DOI":"10.21037\/tau-23-533","article-title":"Extracellular vesicles and prostate cancer management: a narrative review","volume":"13","author":"Urabe","year":"2024","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.bcp.2026.118333_b0425","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1021\/cr500452k","article-title":"Protein lysine acetylation by p300\/CBP","volume":"115","author":"Dancy","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bcp.2026.118333_b0430","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1038\/s41388-025-03417-w","article-title":"Therapeutic targeting of the p300\/CBP bromodomain enhances the efficacy of immune checkpoint blockade therapy","volume":"44","author":"Liu","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.118333_b0435","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1158\/1538-7445.AM2022-1345","article-title":"p300\/CBP bromodomain inhibitor CCS1477 enhances the efficacy of immune checkpoint blockade therapy in cancer treatment","volume":"82","author":"Liu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118333_b0440","article-title":"Inhibiting extracellular vesicles formation and release: a review of EV inhibitors","volume":"9","author":"Catalano","year":"2020","journal-title":"J. Extracell. Ves."},{"key":"10.1016\/j.bcp.2026.118333_b0445","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12865-022-00514-3","article-title":"Blockade of exosome generation by GW4869 inhibits the education of M2 macrophages in prostate cancer","volume":"23","author":"Peng","year":"2022","journal-title":"BMC Immunol."},{"key":"10.1016\/j.bcp.2026.118333_b0450","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.3390\/cancers14184412","article-title":"Prostate cancer tumor stroma: responsibility in tumor biology, diagnosis and treatment","volume":"14","author":"Gonzalez","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2026.118333_b0455","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1158\/1078-0432.CCR-20-4790","article-title":"Radium-223 treatment increases immune checkpoint expression in extracellular vesicles from the metastatic prostate cancer bone microenvironment","volume":"27","author":"Vardaki","year":"2021","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118333_b0460","article-title":"The role of extracellular vesicles in the treatment of prostate cancer","volume":"20","author":"Hu","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.bcp.2026.118333_b0465","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/pros.23996","article-title":"Antitumor efficacy of interferon-\u03b3-modified exosomal vaccine in prostate cancer","volume":"80","author":"Shi","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.bcp.2026.118333_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122894","article-title":"Genetically modified extracellular vesicles loaded with activated gasdermin D potentially inhibit prostate-specific membrane antigen-positive prostate carcinoma growth and enhance immunotherapy","volume":"315","author":"Gao","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2026.118333_b0475","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12951-024-02496-3","article-title":"Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis","volume":"22","author":"Deng","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bcp.2026.118333_b0480","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1080\/10717544.2022.2044937","article-title":"Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bcp.2026.118333_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120946","article-title":"Urinary exosomes-based engineered nanovectors for homologously targeted chemo-chemodynamic prostate cancer therapy via abrogating EGFR\/AKT\/NF-kB\/IkB signaling","volume":"275","author":"Pan","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2026.118333_b0490","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jconrel.2024.12.010","article-title":"Extracellular vesicles-based vaccines: Emerging immunotherapies against cancer","volume":"378","author":"Meng","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bcp.2026.118333_b0495","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.3390\/ijms21062118","article-title":"Exosomes in prostate cancer diagnosis, prognosis and therapy","volume":"21","author":"Lorenc","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118333_b0500","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1158\/0008-5472.CAN-10-4076","article-title":"Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy","volume":"71","author":"Rountree","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118333_b0505","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1466766","article-title":"Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer","volume":"7","author":"van de Ven","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bcp.2026.118333_b0510","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41389-017-0022-6","article-title":"Extracellular vesicle-mediated EBAG9 transfer from cancer cells to tumor microenvironment promotes immune escape and tumor progression","volume":"7","author":"Miyazaki","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bcp.2026.118333_b0515","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.actbio.2022.01.005","article-title":"Exosome-mediated delivery of transforming growth factor-\u03b2 receptor 1 kinase inhibitors and toll-like receptor 7\/8 agonists for combination therapy of tumors","volume":"141","author":"Lee","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2026.118333_b0520","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1016\/j.vaccine.2019.08.033","article-title":"Harnessing T-cell activity against prostate cancer: a therapeutic microparticulate oral cancer vaccine","volume":"37","author":"Parenky","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.bcp.2026.118333_b0525","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00262-025-04070-8","article-title":"Extracellular vesicles derived from mature dendritic cells loaded with cDC1-specific chemokine XCL1 combined with chemotherapy-induced ICD for the treatment of castration-resistant prostate cancer","volume":"74","author":"Fan","year":"2025","journal-title":"Cancer Immunol. Immunother."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:25:45Z","timestamp":1791908745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":105,"alternative-id":["S0006295226006726"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118333","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the extracellular vesicle-immune axis in prostate cancer: mechanisms of immune evasion and emerging therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118333"}}